IP Library › Assignment 072111/0007
Patent Assignment
Reel/Frame 072111/0007

Change of Name

Recorded: 2025-08-25 Pages: 12
Assignor
ICHNOS SCIENCES SA
Executed: 2025-05-27
Assignee
IGI THERAPEUTICS SA
CHEMIN DE LA COMBETA 5, LA CHAUX-DE-FONDS, 2300, SWITZERLAND
Covered Properties (23)
Methods of Inactivating Viral Contaminants
Application: 18/296,250 →
Publication: US US20240002434A1
Antibodies That Bind to IL1RAP and Uses Thereof
Application: 18/600,479 →
Publication: US US20240327530A1
Antibodies That Bind to IL1RAP and Uses Thereof
Application: 18/600,484 →
Publication: US US20240327531A1
Antibodies That Bind to IL1RAP and Uses Thereof
Application: 19/228,477 →
Publication: US US20250361310A1
CD47-CD38 Bispecific Antibodies
Application: 18/484,908 →
Publication: US US20240141062A1
CD47-CD38 Bispecific Antibodies
Application: 18/484,911 →
Publication: US US20240150489A1
CD47-CD38 Bispecific Antibodies
Application: 19/210,823 →
Publication: US US20260071000A1
Antibody Formulation Diluent
Application: 18/000,851 →
Publication: US US20240092903A1
CD3/BCMA/CD38 Trispecific Antibodies
Application: 18/312,519 →
Publication: US US20240228650A9
CD47/CD38 Bispecific Antibodies and Methods of Use to Treat Leukemia
Application: 19/135,726 →
Methods of Inactivating Viral Contaminants with a Mixture of Solvent and Detergent
Application: 18/695,671 →
Publication: US US20260132167A1
Antibodies That Bind to OX40 and Their Uses
Patent: 8,748,585 →
Application: 13/545,708 →
Publication: US US20130183315A1
Production of T cell retargeting hetero-dimeric immunoglobulins
Patent: 9,493,563 →
Application: 14/532,923 →
Publication: US US20150133640A1
Production of T Cell Retargeting Hetero-Dimeric Immunoglobulins
Application: 15/984,822 →
Publication: US US20180355064A1
Production of T Cell Retargeting Hetero-Dimeric Immunoglobulins
Application: 16/931,506 →
Publication: US US20210171661A1
Hetero-Dimeric Immunoglobulins
Patent: 9,683,052 →
Application: 13/695,773 →
Publication: US US20140066599A2
Hetero-Dimeric Immunoglobulins
Patent: 9,683,053 →
Application: 14/167,712 →
Publication: US US20140187753A1
CD3/CD38 T Cell Retargeting Hetero-Dimeric Immunoglobulins and Methods of Their Production
Application: 16/159,231 →
Publication: US US20190135918A1
CD3/CD38 T Cell Retargeting Hetero-Dimeric Immunoglobulins and Methods of Their Production
Application: 17/806,218 →
Publication: US US20230062624A1
Methods of Inactivating Viral Contaminants
Application: 16/641,281 →
Publication: US US20200369747A1
Methods of Inactivating Viral Contaminants
Application: 17/100,236 →
Publication: US US20210324000A1
Antibodies That Bind to IL1RAP and Uses Thereof
Application: 17/474,837 →
Publication: US US20220089754A1
CD47-CD38 Bispecific Antibodies
Application: 17/478,706 →
Publication: US US20220089767A1
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 8, 2013
From: BLEIN, STANISLAS; SKEGRO, DARKO; WASSMANN, PAUL
To: GLENMARK PHARMACEUTICALS S.A.
Reel/Frame 029587/0927 →
Assignment of Assignor's Interest Jan 25, 2013
From: ATTINGER, ANTOINE; BLEIN, STANISLAS; BACK, JONATHAN ALBERT; LISSILAA, RAMI
To: GLENMARK PHARMACEUTICALS S.A.
Reel/Frame 029693/0732 →
Assignment of Assignor's Interest May 15, 2014
From: BLEIN, STANISLAS; SKEGRO, DARKO; WASSMANN, PAUL
To: GLENMARK PHARMACEUTICALS S.A.
Reel/Frame 032903/0779 →
Assignment of Assignor's Interest Oct 5, 2016
From: BLEIN, STANISLAS; OLLIER, ROMAIN; SKEGRO, DARKO; HOU, SAMUEL
To: GLENMARK PHARMACEUTICALS S.A.
Reel/Frame 039943/0119 →
Assignment of Assignor's Interest Jan 14, 2019
From: OLLIER, ROMAIN; HOU, SAMUEL; LISSILAA, RAMI; SKEGRO, DARKO
To: GLENMARK PHARMACEUTICALS S.A.
Reel/Frame 047988/0925 →
Change of Name Jan 31, 2020
From: GLENMARK PHARMACEUTICALS S.A.
To: ICHNOS SCIENCES SA
Reel/Frame 052159/0045 →
Assignment of Assignor's Interest Feb 27, 2020
From: BLEIN, STANISLAS; OLLIER, ROMAIN; SKEGRO, DARKO; HOU, SAMUEL
To: GLENMARK PHARMACEUTICALS S.A.
Reel/Frame 051946/0893 →
Change of Name Mar 20, 2020
From: GLENMARK PHARMACEUTICALS S.A.
To: ICHNOS SCIENCES SA
Reel/Frame 052202/0987 →
Assignment of Assignor's Interest Aug 4, 2020
From: ABRANTES, FILIPA; LETESTU, SONIA; CAHUZAC, LAURE; DUARTE, LIONEL
To: ICHNOS SCIENCES SA
Reel/Frame 053838/0549 →
Change of Name May 27, 2021
From: GLENMARK PHARMACEUTICALS S.A.
To: ICHNOS SCIENCES SA
Reel/Frame 056412/0700 →
Assignment of Assignor's Interest May 28, 2021
From: BLEIN, STANISLAS; OLLIER, ROMAIN; SKEGRO, DARKO; HOU, SAMUEL
To: GLENMARK PHARMACEUTICALS S.A.
Reel/Frame 056379/0808 →
Assignment of Assignor's Interest Aug 2, 2022
From: OLLIER, ROMAIN; HOU, SAMUEL; LISSILAA, RAMI; SKEGRO, DARKO
To: GLENMARK PHARMACEUTICALS S.A.
Reel/Frame 060697/0595 →
Change of Name Aug 19, 2022
From: GLENMARK PHARMACEUTICALS S.A.
To: ICHNOS SCIENCES SA
Reel/Frame 061282/0079 →
Assignment of Assignor's Interest Aug 8, 2023
From: ABRANTES, FILIPA; LETESTU, SONIA; CAHUZAC, LAURE; DUARTE, LIONEL
To: ICHNOS SCIENCES SA
Reel/Frame 064526/0640 →
Assignment of Assignor's Interest Oct 10, 2023
From: DUBEY, SACHIN; GASSIAT, BRICE
To: ICHNOS SCIENCES SA
Reel/Frame 065166/0760 →
Assignment of Assignor's Interest Jul 3, 2024
From: PIHLGREN BOSCH, MARIA; PERRO, MARIO; HALL, OLIVIA; CARRETERO IGLESIA, LAURA
To: ICHNOS SCIENCES SA
Reel/Frame 067910/0577 →
Assignment of Assignor's Interest Jul 8, 2024
From: MACOIN, JULIE; CROSET, AMELIE; LOYAU, JEREMY; MONNEY, THIERRY
To: ICHNOS SCIENCES SA
Reel/Frame 067923/0527 →
Assignment of Assignor's Interest Jul 10, 2024
From: BOUCHEZ, LAURE; POULEAU, BLANDINE; DOUCEY, MARIE-AGNES; DHEILLY, ELIE
To: ICHNOS SCIENCES SA
Reel/Frame 067950/0121 →
Assignment of Assignor's Interest Dec 4, 2024
From: BOUCHEZ, LAURE; POULEAU, BLANDINE; DOUCEY, MARIE-AGNES; DHEILLY, ELIE
To: ICHNOS SCIENCES SA
Reel/Frame 069487/0204 →
Assignment of Assignor's Interest Jun 6, 2025
From: BOUCHEZ, LAURE; POULEAU, BLANDINE; DOUCEY, MARIE-AGNES; DHEILLY, ELIE
To: ICHNOS SCIENCES SA
Reel/Frame 071346/0635 →